脊椎固定デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

世界の脊椎固定デバイスの市場規模は、2023年に64億9,000万米ドル、2030年までに84億7,000万米ドルに達し、2024年～2030年の予測期間にCAGRで4.55％の成長が見込まれます。脊椎固定デバイスに対する需要の増加は、主に、世界の老年人口の増加による椎間板変性症、脊椎すべり症、椎間板ヘルニア、脊柱管狭窄症などの脊椎疾患の有病率の上昇、低侵襲手術に対する需要の増加によるものです。さらに、製品ラインの技術の進歩や新製品の発売なども、世界の脊椎固定デバイス市場を牽引すると予測されます。

脊椎固定デバイスの市場力学

脊椎固定術は、脊椎の小骨に関連する障害を改善するために用いられます。この手術では、椎間板変性症、椎骨骨折、脊椎すべり症、椎間板ヘルニア、脊柱管狭窄症などの治療に向け、脊椎の2つ以上の椎骨を固定します。近年、脊椎固定術の件数は徐々に増加しています。これは、主に加齢、交通事故、転倒、暴力などが原因で、脊椎に関連するさまざまな変形が増加しているためです。非政府組織であるSpinal Cord Injuries Australia（2022）の統計によると、約1万5,000人の人々が脊髄損傷（SCI）を抱えて生活しています。また、このデータによると、交通事故による外傷性脊髄損傷は全症例の46％であるのに対し、転倒による外傷性脊髄損傷が全症例の約36％を占めています。同様に、英国の脊髄損傷者の支援を行うSpinal Injuries Association、Aspire、Back Upの3つの主要慈善団体による近年の推計（2020～2022）によると、英国で人生を変えるような脊髄損傷を負ったり診断されたりした人の数は年間2,500人であり、一方、英国で脊髄損傷とともに暮らす人の総数は5ｍ、万人です。以前はNHS（National Health Service）自体も含め、毎年1,000人しか負傷または診断されておらず、脊髄損傷とともに生きる人の総数は4万人であると広く考えられていました。さらに、National Spinal Cord Injury Database 2019によると、米国における脊髄損傷（SCI）の年間罹患率は100万人あたり約54件であり、毎年約1万7,730人が新たにSCIを発症し、有病者数は約29万1,000人で、24万9,000人～36万3,000人の幅があります。このように、脊髄損傷の症例が多いことが、世界の脊椎固定デバイス市場を後押ししています。

さらに、世界中で老年人口の負担が増大していることも、市場の成長に寄与すると予測されます。高齢者は脊椎に関連する障害や疾患を発症しやすいからです。例えば、WHO（2018）のレポートによると、2050年までに世界の60歳以上の人口は20億人になり、5歳未満の子供の数を上回ると予測されています。

さらに、標準的な観血的アプローチと比較して、切開創が小さい、筋肉損傷が少ない、出血が少ない、手術後の入院期間が短いなどの利点から、低侵襲脊椎固定術の需要が増加していることも、予測期間に世界の脊椎固定デバイスの増加に寄与します。

脊椎固定デバイスに対する厳格な規制や少数の製品リコールなどの特定の要因は、脊椎固定デバイス市場の成長にとって小さな障害となる可能性があります。

脊椎固定デバイスのセグメント分析

脊椎固定デバイス製品セグメントでは、予測期間に胸腰椎デバイスが最大の市場シェアを占めると予測されます。これは、さまざまな胸腰椎固定デバイスが利用できるためです。また、世界の腰椎変性の有病率の上昇が、世界の脊椎固定デバイス市場のセグメント成長に寄与する主な促進要因となっています。例えば、2018年にNCBIで公開されたRavindra M.V.らによる「Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume」という調査によると、世界で合計2億6,600万人（3.63％）が毎年腰椎変性脊椎疾患（DSD）と腰痛（LBP）を患っています。

当レポートでは、世界の脊椎固定デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 脊椎固定デバイスレポートのイントロダクション

第2章 脊椎固定デバイスのエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価
• 財務ベンチマーク

第3章 規制と特許の分析

• 米国
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • 英国
• 日本

第4章 脊椎固定デバイス市場の主な要因の分析

• 脊椎固定デバイス市場の促進要因
  • 脊椎変形の有病率の増加
  • 老年人口の増加
  • 低侵襲手術に対する需要の高まり
  • 先進技術を利用した製品の発売
• 脊椎固定デバイス市場の抑制要因と課題
  • 少数の製品リコール
  • 脊椎関連デバイスの厳しい規制
• 脊椎固定デバイス市場の機会
  • 3Dプリンティングとロボット支援脊椎手術による機会の拡大
  • 発展途上国における成長機会

第5章 脊椎固定デバイスのポーターのファイブフォース分析

第6章 脊椎固定デバイス市場に対するCOVID-19の影響分析

第7章 脊椎固定デバイス市場のレイアウト

• 製品タイプ別
  • 胸腰椎デバイス
  • 頸椎デバイス
  • 椎体間固定デバイス
• 適応症別
  • 椎間板変性疾患
  • 複雑な変形
  • 外傷・骨折
  • その他
• エンドユーザー別
  • 病院
  • 整形外科クリニック
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 脊椎固定デバイス：世界の企業シェア分析 - 主要3～5社

第9章 脊椎固定デバイスの企業と製品のプロファイル

• Zimmer Biomet
• Stryker
• Medtronic
• Orthofix Medical Inc.
• NuVasive Inc.
• B. Braun Melsungen AG
• XTANT MEDICAL
• Globus Medical
• ATEC Spine, Inc
• Medacta International
• Johnson & Johnson Services, Inc. (DePuy Synthes)
• Captiva Spine, Inc.
• ZAVATION

第10章 プロジェクトのアプローチ

• 二次資料
• 一次資料
• データの三角測量
• 主な専門家の意見

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Spinal Fusion Devices Market Analysis
• Table 3: Spinal Fusion Devices Market Analysis in Global (2021-2030)
• Table 4: Spinal Fusion Devices Market Analysis in Global by Product Type (2021-2030)
• Table 5: Spinal Fusion Devices Market Analysis in Global by Indication (2021-2030)
• Table 6: Spinal Fusion Devices Market Analysis in Global by End User (2021-2030)
• Table 7: Spinal Fusion Devices Market Analysis in Global by Geography (2021-2030)
• Table 8: Spinal Fusion Devices Market Analysis in North America (2021-2030)
• Table 9: Spinal Fusion Devices Market Analysis in North America by Product Type (2021-2030)
• Table 10: Spinal Fusion Devices Market Analysis in North America by Indication (2021-2030)
• Table 11: Spinal Fusion Devices Market Analysis in North America by End User (2021-2030)
• Table 12: Spinal Fusion Devices Market Analysis in North America by Country (2021-2030)
• Table 13: Spinal Fusion Devices Market Analysis in the US (2021-2030)
• Table 14: Spinal Fusion Devices Market Analysis in Canada (2021-2030)
• Table 15: Spinal Fusion Devices Market Analysis in Mexico (2021-2030)
• Table 16: Spinal Fusion Devices Market Analysis in Europe (2021-2030)
• Table 17: Spinal Fusion Devices Market Analysis in Europe by Product Type (2021-2030)
• Table 18: Spinal Fusion Devices Market Analysis in Europe by Indication (2021-2030)
• Table 19: Spinal Fusion Devices Market Analysis in Europe by End User (2021-2030)
• Table 20: Spinal Fusion Devices Market Analysis in Europe by Country (2021-2030)
• Table 21: Spinal Fusion Devices Market Analysis in France (2021-2030)
• Table 22: Spinal Fusion Devices Market Analysis in Germany (2021-2030)
• Table 23: Spinal Fusion Devices Market Analysis in the UK (2021-2030)
• Table 24: Spinal Fusion Devices Market Analysis in Italy (2021-2030)
• Table 25: Spinal Fusion Devices Market Analysis in Spain (2021-2030)
• Table 26: Spinal Fusion Devices Market Analysis in Russia (2021-2030)
• Table 27: Spinal Fusion Devices Market Analysis in Rest of Europe (2021-2030)
• Table 28: Spinal Fusion Devices Market Analysis in Asia-Pacific (2021-2030)
• Table 29: Spinal Fusion Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
• Table 30: Spinal Fusion Devices Market Analysis in Asia-Pacific by Indication (2021-2030)
• Table 31: Spinal Fusion Devices Market Analysis in Asia-Pacific by End User (2021-2030)
• Table 32: Spinal Fusion Devices Market Analysis in Asia-Pacific by Country (2021-2030)
• Table 33: Spinal Fusion Devices Market Analysis in China (2021-2030)
• Table 34: Spinal Fusion Devices Market Analysis in Japan (2021-2030)
• Table 35: Spinal Fusion Devices Market Analysis in India (2021-2030)
• Table 36: Spinal Fusion Devices Market Analysis in Australia (2021-2030)
• Table 37: Spinal Fusion Devices Market Analysis in South Korea (2021-2030)
• Table 38: Spinal Fusion Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
• Table 39: Spinal Fusion Devices Market Analysis in Rest of World (2021-2030)
• Table 40: Spinal Fusion Devices Market Analysis in Rest of World by Product Type (2021-2030)
• Table 41: Spinal Fusion Devices Market Analysis in Rest of World by Indication (2021-2030)
• Table 42: Spinal Fusion Devices Market Analysis in Rest of World by End User (2021-2030)
• Table 43: Spinal Fusion Devices Market Analysis in Rest of World by Country (2021-2030)
• Table 44: Spinal Fusion Devices Market Analysis in Middle East (2021-2030)
• Table 45: Spinal Fusion Devices Market Analysis in Africa (2021-2030)
• Table 46: Spinal Fusion Devices Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Spinal Fusion Devices Market Analysis
• Figure 3: Spinal Fusion Devices Market Analysis in Global (2021-2030)
• Figure 4: Spinal Fusion Devices Market Analysis in Global by Product Type (2021-2030)
• Figure 5: Spinal Fusion Devices Market Analysis in Global by Indication (2021-2030)
• Figure 6: Spinal Fusion Devices Market Analysis in Global by End User (2021-2030)
• Figure 7: Spinal Fusion Devices Market Analysis in Global by Geography (2021-2030)
• Figure 8: Spinal Fusion Devices Market Analysis in North America (2021-2030)
• Figure 9: Spinal Fusion Devices Market Analysis in North America by Product Type (2021-2030)
• Figure 10: Spinal Fusion Devices Market Analysis in North America by Indication (2021-2030)
• Figure 11: Spinal Fusion Devices Market Analysis in North America by End User (2021-2030)
• Figure 12: Spinal Fusion Devices Market Analysis in North America by Country (2021-2030)
• Figure 13: Spinal Fusion Devices Market Analysis in the US (2021-2030)
• Figure 14: Spinal Fusion Devices Market Analysis in Canada (2021-2030)
• Figure 15: Spinal Fusion Devices Market Analysis in Mexico (2021-2030)
• Figure 16: Spinal Fusion Devices Market Analysis in Europe (2021-2030)
• Figure 17: Spinal Fusion Devices Market Analysis in Europe by Product Type (2021-2030)
• Figure 18: Spinal Fusion Devices Market Analysis in Europe by Indication (2021-2030)
• Figure 19: Spinal Fusion Devices Market Analysis in Europe by End User (2021-2030)
• Figure 20: Spinal Fusion Devices Market Analysis in Europe by Country (2021-2030)
• Figure 21: Spinal Fusion Devices Market Analysis in France (2021-2030)
• Figure 22: Spinal Fusion Devices Market Analysis in Germany (2021-2030)
• Figure 23: Spinal Fusion Devices Market Analysis in the UK (2021-2030)
• Figure 24: Spinal Fusion Devices Market Analysis in Italy (2021-2030)
• Figure 25: Spinal Fusion Devices Market Analysis in Spain (2021-2030)
• Figure 26: Spinal Fusion Devices Market Analysis in Russia (2021-2030)
• Figure 27: Spinal Fusion Devices Market Analysis in Rest of Europe (2021-2030)
• Figure 28: Spinal Fusion Devices Market Analysis in Asia-Pacific (2021-2030)
• Figure 29: Spinal Fusion Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
• Figure 30: Spinal Fusion Devices Market Analysis in Asia-Pacific by Indication (2021-2030)
• Figure 31: Spinal Fusion Devices Market Analysis in Asia-Pacific by End User (2021-2030)
• Figure 32: Spinal Fusion Devices Market Analysis in Asia-Pacific by Country (2021-2030)
• Figure 33: Spinal Fusion Devices Market Analysis in China (2021-2030)
• Figure 34: Spinal Fusion Devices Market Analysis in Japan (2021-2030)
• Figure 35: Spinal Fusion Devices Market Analysis in India (2021-2030)
• Figure 36: Spinal Fusion Devices Market Analysis in Australia (2021-2030)
• Figure 37: Spinal Fusion Devices Market Analysis in South Korea (2021-2030)
• Figure 38: Spinal Fusion Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
• Figure 39: Spinal Fusion Devices Market Analysis in Rest of World (2021-2030)
• Figure 40: Spinal Fusion Devices Market Analysis in Rest of World by Product Type (2021-2030)
• Figure 41: Spinal Fusion Devices Market Analysis in Rest of World by Indication (2021-2030)
• Figure 42: Spinal Fusion Devices Market Analysis in Rest of World by End User (2021-2030)
• Figure 43: Spinal Fusion Devices Market Analysis in Rest of World by Country (2021-2030)
• Figure 44: Spinal Fusion Devices Market Analysis in Middle East (2021-2030)
• Figure 45: Spinal Fusion Devices Market Analysis in Africa (2021-2030)
• Figure 46: Spinal Fusion Devices Market Analysis in South America (2021-2030)
• Figure 47: Market Drivers
• Figure 48: Market Barriers
• Figure 49: Market Opportunities
• Figure 50: PORTER's Five Force Analysis

Spinal Fusion Devices Market By Product Type (Thoracolumbar Devices, Cervical Devices, And Interbody Fusion Devices ), By Indication (Degenerative Disc Disorders, Complex Deformity, Trauma & Fractures, And Others), By End-User (Hospitals, Orthopedic Clinics, And Others), by geography is expected to grow at a significant CAGR forecast till 2030 owing to increasing spinal deformities and rise in demand for minimally invasive surgeries

Global Spinal Fusion Devices Market was valued at USD 6.49 billion in 2023, growing at a CAGR of 4.55% during the forecast period from 2024 to 2030 to reach USD 8.47 billion by 2030. The rise in demand for Spinal Fusion Devices is primarily attributed to the rising prevalence of spinal disorders such as degenerative disc disorders, spondylolisthesis, disc herniation, spinal stenosis among the growing old-age population worldwide; increase in demand for minimally invasive surgeries. In addition, technological advancement in the product line, and new product launches among others are also expected to drive the global spinal fusion market.

Spinal Fusion Devices Market Dynamics:

Spinal Fusion surgery is used to rectify disorders related with small bones in the spine. The procedure involves fusion of two or more vertebrae in the vertebral column for the treatment of degenerative discs, fractured vertebra, spondylolisthesis, disc herniation, and spinal canal stenosis, among others. In recent years, the number of spine fusion surgeries has gradually increased. This is owing to the rising prevalence of various spine associated deformities caused primarily due to aging, road traffic crashes, falls or violence. According to the Spinal Cord Injuries Australia, a non-government organization, statistics 2022, approximately 15000 of the population live with a spinal cord injury (SCI). Also according to the data, traumatic spinal cord injury due to traffic crashes contributed to 46% of all the cases whereas falls contributed to around 36% of all the traumatic SCI cases. Similarly, according to the recent estimates (2020-2022) by the three leading charities: Spinal Injuries Association, Aspire and Back Up providing support to the spinal cord injured people in the UK that the number of people injured or diagnosed with a life-changing spinal cord injury in the UK is 2,500 per year, whilst the total number of people living with a spinal cord injury in the UK is 50,000. Previously it was widely believed, including by the (National Health Service) NHS itself, that only 1,000 people were injured or diagnosed each year and that the total number of people living with a spinal cord injury was 40,000. Moreover, according to the National Spinal Cord Injury Database 2019, the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, or about 17,730 new SCI cases each year and the prevalence is approximately 291,000 persons, with a range from 249,000 to 363,000 persons. Thus, the high cases of spinal cord injuries is propelling the market for the global spinal fusion devices.

Furthermore, rising burden of geriatric population across the globe is also expected to contribute to the market growth. This is because old population are more susceptible for developing spine associated disorders and ailments. For instance, according to WHO 2018 report, by 2050, the world's population aged 60 years and older was expected to total 2 billion and will outnumber children younger than 5 years.

In addition, increasing demand for the minimally invasive spine fusion surgeries due to advantages such as smaller incisions, less muscle damage, decreased blood loss and length of hospital stay following surgery in comparison to standard open approach will also contribute to the global spinal fusion devices during the forecasted period.

Certain factors such as stringent regulation for the spinal devices, and few product recalls may pose a minor hurdle for the growth of the Spinal Fusion Devices market.

Spinal Fusion Devices Segment Analysis:

Spinal Fusion Devices Market By Product Type (Thoracolumbar Devices, Cervical Devices, and Interbody Fusion Devices), By Indication (Degenerative Disc Disorders, Complex Deformity, Trauma & Fractures, and Others), By End-User (Hospitals, Orthopedic Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

]In Spinal Fusion Devices product segment, the thoracolumbar devices is anticipated to hold the largest market share during the forecasted period. This is due to the availability of a variety of thoracolumbar fixation devices. In addition, rising prevalence of lumbar spine degeneration worldwide are the major driving factors contributing to the segmental growth of the global spinal fusion devices market. For instance, according to a study: Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume by Ravindra M.V. et al., published in NCBI in the year 2018, a total of 266 million individuals (3.63%) worldwide were found to have Lumbar degenerative spine disease (DSD) and low back pain (LBP) annually.

Moreover, recent product approval in is also anticipated to further boost the segmental market of the spinal fusion devices. For instance, in August 2020, Orion Biotech Inc. received the US Food & Drug Administration (FDA) approval for Thoracolumbosacral Pedicle Screw System intended to provide posterior, non-cervical immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine : degenerative spondylolisthesis with objective evidence of neurological impairment; fracture; dislocation; scoliosis; kyphosis; spinal stenosis; tumor; pseudarthrosis and/or failed previous fusion. Therefore, aforementioned factors are likely to propel the segmental growth of Spinal Fusion Devices market.

North America is expected to dominate the Overall Spinal Fusion Devices Market:

Among all the region, North America is expected to dominate the overall Spinal Fusion Devices market during the forecast period. This domination is due to the improved healthcare infrastructure, favourable reimbursement scenario in the region.

Further, in the United States the rising prevalence of low back pain (LBP) among the population is expected to boost the spinal fusion devices market in the region. For instance, according to CDC 2022 report, approximately 25% of U.S. adults report LBP. Also, according to the Canadian Chiropractic Association 2018 data, five in 10 Canadians suffered low back pain.

Moreover, adoption of technologically advancement such as surgical robots for the spine surgery in the region is also expected to grow the spinal fusion devices market. For instance, in 2019, Medtronic launched the Mazor X Stealth(TM) Edition for Robotic-Assisted Spine Surgery. Also, rising spinal fusion surgery volume is also a factor that is anticipated to augment the spinal fusion devices in the region. According to a study: Predicting Trends in Cervical Spinal Surgery in the United States from 2020 to 2040 by Neifert S.N. et al., published in NCBI in the year 2020, it was expected that there would be an increase of 13.3% and 19.3% for anterior cervical discectomy and fusion (ACDF) and posterior cervical decompression and fusion (PCDF) from the year 2020-2040.

Additionally, presence of key market players such as Medtronic, Zimmer Biomet, and Orthofix among other and their strategic business development activities in the region is also a fuelling factor of the spinal fusion devices in the region. For instance, in September 2020, Orthofix Medical Inc. and Neo Medical SA, announced a partnership and investment agreement to develop and market innovative outcome-driven procedural solutions. The collaboration will focus on developing a cervical platform. Also, under the agreement, Orthofix will also exclusively distribute Neo Medical's disruptive value-based thoracolumbar procedure solutions to certain U.S. accounts.

The Asia-Pacific region has the future potential growth for the Global Spinal Fusion Devices. This is due to the rising burden of geriatric population in the region. Rapid urbanization, increase in disposable income, and growing healthcare awareness about are the factors that are likely to drive the market. In addition, increasing prevalence of spine fractures and degenerative disc disorders in the region and improving reimbursement policies for spine surgeries are also expected to surge the market. For instance, in April 2018, Australian Government announced changes to Medicare funded spinal surgery services by introducing new rules to ensure consistent and appropriate claiming.

Spinal Fusion Devices Market Key Players:

Some of the key market players operating in the Spinal Fusion Devices market includes Medtronic, Johnson & Johnson Services, Inc., Zimer Biomet, Stryker, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, and others.

Recent Developmental Activities in the Spinal Fusion Devices Market:

In March 2022, Aurora Spine Corporation successfully launched its Proprietary SiLO(TM) Posterior SI Joint Fusion System.

In September 2020, Royal Biologics acquired FIBRINET. The acquisition comes as part of Royal Biologics' strategic initiative to add novel technologies to its growing portfolio of autologous and live cellular solutions to support orthopedic and spinal fusion.

In July 2020, Zavation Medical Products, LLC. launched Z-Span Expandable Anterior and Lateral Lumbar Plates.

Key Takeaways from the Spinal Fusion Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Spinal Fusion market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Spinal Fusion Devices Market.

Various opportunities available for the other competitor in the Spinal Fusion Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Spinal Fusion Devices market growth in the coming future?

Target Audience who can be benefited from Spinal Fusion Devices Market Report Study

Spinal Fusion Devices providers

Research organizations and consulting companies

Spinal Fusion-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Spinal Fusion Devices

Various End-users who want to know more about the Spinal Fusion Devices Market and the latest technological developments in the Spinal Fusion Devices market.

Frequently Asked Questions for Spinal Fusion Devices Market:

1. What are Spinal Fusion Devices?

Spinal Fusion are devices connect two or more vertebrae in the spine to improve stability, correct a deformity or reduce pain.

2. What is the market for Global Spinal Fusion Devices?

Global Spinal Fusion Devices Market was valued at USD 6.49 billion in 2023, growing at a CAGR of 4.55% during the forecast period from 2024 to 2030 to reach USD 8.47 billion by 2030.

3. What are the drivers for Global Spinal Fusion Devices?

The major factors driving the demand for Spinal Fusion are the growing geriatric population coupled with the rising spine deformities, increasing demand for minimally invasive surgeries, and the launch of technically advanced products in the market.

4. What are the key players operating in Global Spinal Fusion Devices?

Some of the key market players operating in the Spinal Fusion Devices market includes Medtronic, Johnson & Johnson Services, Inc., Zimmer Biomet, Stryker, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, and others.

5. What regions have the highest share in Spinal Fusion Devices market?

North America is expected to dominate the overall Spinal Fusion Devices market during the forecast period. This domination is due to the improved healthcare infrastructure, favourable reimbursement scenario in the region. Moreover, presence of key market players, and rising spinal fusion surgeries in the region is also expected to bolster the market.

Table of Contents

1.Spinal Fusion Devices Report Introduction

2.Spinal Fusion Devices Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
  • 3.2.1. Germany
  • 3.2.2. France
  • 3.2.3. Italy
  • 3.2.4. Spain
  • 3.2.5. U.K.
• 3.3. Japan

4. Spinal Fusion Devices Market Key factors analysis

• 4.1. Spinal Fusion Devices Market Drivers
  • 4.1.1. Increasing prevalence of Spine deformities
  • 4.1.2. Growing geriatric population
  • 4.1.3. Rising demand for minimally invasive surgeries
  • 4.1.4. Launch of technologically advanced products
• 4.2. Spinal Fusion Devices Market Restraints and Challenges
  • 4.2.1. Few Product recalls
  • 4.2.2. Stringent regulation of spine related devices
• 4.3. Spinal Fusion Devices Market Opportunities
  • 4.3.1. Growing opportunity with 3-D printing & robot assisted spinal procedures
  • 4.3.2. Growth opportunities in developing nations

5. Spinal Fusion Devices Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Spinal Fusion Devices Market

7. Spinal Fusion Devices Market layout

• 7.1. By Product Type
  • 7.1.1. Thoracolumbar Devices
  • 7.1.2. Cervical Devices
  • 7.1.3. Interbody Fusion devices
• 7.2. By Indication
  • 7.2.1. Degenerative Disc Disorders
  • 7.2.2. Complex Deformities
  • 7.2.3. Trauma & Fractures
  • 7.2.4. Others
• 7.3. By End-user
  • 7.3.1. Hospitals
  • 7.3.2. Orthopedic Clinics
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Spinal Fusion Devices Market, by Product Type
    • 7.4.1.2. North America Spinal Fusion Devices Market, by Indication
    • 7.4.1.3. North America Spinal Fusion Devices Market, by End User
    • 7.4.1.4. North America Spinal Fusion Devices Market, by Country
    • 7.4.1.4.1. United States
    • 7.4.1.4.2. Canada
    • 7.4.1.4.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Spinal Fusion Devices Market, by Product Type
    • 7.4.2.2. Europe Spinal Fusion Devices Market, by Indication
    • 7.4.2.3. Europe Spinal Fusion Devices Market, by End User
    • 7.4.2.4. Europe Spinal Fusion Devices Market, by Country
    • 7.4.2.4.1. France
    • 7.4.2.4.2. Germany
    • 7.4.2.4.3. United Kingdom
    • 7.4.2.4.4. Italy
    • 7.4.2.4.5. Spain
    • 7.4.2.4.6. Russia
    • 7.4.2.4.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Spinal Fusion Devices Market, by Product Type
    • 7.4.3.2. Asia-Pacific Spinal Fusion Devices Market, by Indication
    • 7.4.3.3. Asia-Pacific Spinal Fusion Devices Market, by End User
    • 7.4.3.4. Asia-Pacific Spinal Fusion Devices Market, by Country
    • 7.4.3.4.1. China
    • 7.4.3.4.2. Japan
    • 7.4.3.4.3. India
    • 7.4.3.4.4. Australia
    • 7.4.3.4.5. South Korea
    • 7.4.3.4.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW Spinal Fusion Devices Market, by Product Type
    • 7.3.4.2. RoW Spinal Fusion Devices Market, by Indication
    • 7.4.4.3. RoW Spinal Fusion Devices Market, by End User
    • 7.4.4.4. RoW Spinal Fusion Devices Market, by Region
    • 7.4.4.4.1. Middle East
    • 7.4.4.4.2. Africa
    • 7.4.4.4.3. South America

8. Spinal Fusion Devices Global Company Share Analysis - Key 3-5 Companies

9. Spinal Fusion Devices Company and Product Profiles

• 9.1. Zimmer Biomet
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Stryker
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Medtronic
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Orthofix Medical Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. NuVasive Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. B. Braun Melsungen AG
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. XTANT MEDICAL
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Globus Medical
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. ATEC Spine, Inc
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Medacta International
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Johnson & Johnson Services, Inc. (DePuy Synthes)
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Captiva Spine, Inc.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. ZAVATION
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy

10. Project Approach

• 10.1. Secondary Sources
• 10.2. Primary Sources
• 10.3. Data Triangulation
• 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight